Stephen Dilly

Shortly after selling Sierra to GSK, Stephen Dilly heads to enzyme engineer Codexis as new CEO
Endpoints
Tue, 07/19/22 - 10:24 am
Sierra Oncology
Stephen Dilly
GSK
Codexis